Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society.

Barboi A, Gibbons CH, Axelrod F, Benarroch EE, Biaggioni I, Chapleau MW, Chelimsky G, Chelimsky T, Cheshire WP, Claydon VE, Freeman R, Goldstein DS, Joyner MJ, Kaufmann H, Low PA, Norcliffe-Kaufmann L, Robertson D, Shibao CA, Singer W, Snapper H, Vernino S, Raj SR; American Autonomic Society.

Auton Neurosci. 2020 Jan;223:102550. doi: 10.1016/j.autneu.2019.05.002.

PMID:
31928708
2.

Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society.

Barboi A, Gibbons CH, Axelrod F, Benarroch EE, Biaggioni I, Chapleau MW, Chelimsky G, Chelimsky T, Cheshire WP, Claydon VE, Freeman R, Goldstein DS, Joyner MJ, Kaufmann H, Low PA, Norcliffe-Kaufmann L, Robertson D, Shibao CA, Singer W, Snapper H, Vernino S, Raj SR; American Autonomic Society.

Clin Auton Res. 2020 Feb;30(1):13-18. doi: 10.1007/s10286-019-00608-w. Epub 2019 Sep 2.

PMID:
31475305
3.

Obstructive Sleep-Disordered Breathing Is More Common than Central in Mild Familial Dysautonomia.

Hilz MJ, Moeller S, Buechner S, Czarkowska H, Ayappa I, Axelrod FB, Rapoport DM.

J Clin Sleep Med. 2016 Dec 15;12(12):1607-1614. doi: 10.5664/jcsm.6342.

4.

Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.

Chartier C, Raval J, Axelrod F, Bond C, Cain J, Dee-Hoskins C, Ma S, Fischer MM, Shah J, Wei J, Ji M, Lam A, Stroud M, Yen WC, Yeung P, Cancilla B, O'Young G, Wang M, Kapoun AM, Lewicki J, Hoey T, Gurney A.

Cancer Res. 2016 Feb 1;76(3):713-23. doi: 10.1158/0008-5472.CAN-15-0561. Epub 2015 Dec 30.

5.

Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.

Yen WC, Fischer MM, Axelrod F, Bond C, Cain J, Cancilla B, Henner WR, Meisner R, Sato A, Shah J, Tang T, Wallace B, Wang M, Zhang C, Kapoun AM, Lewicki J, Gurney A, Hoey T.

Clin Cancer Res. 2015 May 1;21(9):2084-95. doi: 10.1158/1078-0432.CCR-14-2808.

6.

Norepinephrine deficiency with normal blood pressure control in congenital insensitivity to pain with anhidrosis.

Norcliffe-Kaufmann L, Katz SD, Axelrod F, Kaufmann H.

Ann Neurol. 2015 May;77(5):743-52. doi: 10.1002/ana.24377. Epub 2015 Mar 13.

7.

Disturbances in affective touch in hereditary sensory & autonomic neuropathy type III.

Macefield VG, Norcliffe-Kaufmann L, Löken L, Axelrod FB, Kaufmann H.

Int J Psychophysiol. 2014 Jul;93(1):56-61. doi: 10.1016/j.ijpsycho.2014.04.002. Epub 2014 Apr 12.

8.

Selective retinal ganglion cell loss in familial dysautonomia.

Mendoza-Santiesteban CE, Hedges Iii TR, Norcliffe-Kaufmann L, Axelrod F, Kaufmann H.

J Neurol. 2014 Apr;261(4):702-9. doi: 10.1007/s00415-014-7258-2. Epub 2014 Feb 2.

PMID:
24487827
9.

Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.

Agnusdei V, Minuzzo S, Frasson C, Grassi A, Axelrod F, Satyal S, Gurney A, Hoey T, Seganfreddo E, Basso G, Valtorta S, Moresco RM, Amadori A, Indraccolo S.

Leukemia. 2014 Feb;28(2):278-88. doi: 10.1038/leu.2013.183. Epub 2013 Jun 18.

PMID:
23774673
10.

Relationship between proprioception at the knee joint and gait ataxia in HSAN III.

Macefield VG, Norcliffe-Kaufmann LJ, Axelrod FB, Kaufmann H.

Mov Disord. 2013 Jun;28(6):823-7. doi: 10.1002/mds.25482. Epub 2013 May 16.

11.

Hyperdopaminergic crises in familial dysautonomia: a randomized trial of carbidopa.

Norcliffe-Kaufmann L, Martinez J, Axelrod F, Kaufmann H.

Neurology. 2013 Apr 23;80(17):1611-7. doi: 10.1212/WNL.0b013e31828f18f0. Epub 2013 Apr 3.

12.

Genetic autonomic disorders.

Axelrod FB.

Semin Pediatr Neurol. 2013 Mar;20(1):3-11. doi: 10.1016/j.spen.2012.12.002. Review.

PMID:
23465768
13.

Cardiac-locked bursts of muscle sympathetic nerve activity are absent in familial dysautonomia.

Macefield VG, Norcliffe-Kaufmann L, Axelrod FB, Kaufmann H.

J Physiol. 2013 Feb 1;591(3):689-700. doi: 10.1113/jphysiol.2012.246264. Epub 2012 Nov 19.

14.

Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors.

Gurney A, Axelrod F, Bond CJ, Cain J, Chartier C, Donigan L, Fischer M, Chaudhari A, Ji M, Kapoun AM, Lam A, Lazetic S, Ma S, Mitra S, Park IK, Pickell K, Sato A, Satyal S, Stroud M, Tran H, Yen WC, Lewicki J, Hoey T.

Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11717-22. doi: 10.1073/pnas.1120068109. Epub 2012 Jul 2.

15.

Cyclic vomiting associated with excessive dopamine in Riley-day syndrome.

Norcliffe-Kaufmann LJ, Axelrod FB, Kaufmann H.

J Clin Gastroenterol. 2013 Feb;47(2):136-8. doi: 10.1097/MCG.0b013e3182582cbf.

16.

A rating scale for the functional assessment of patients with familial dysautonomia (Riley Day syndrome).

Axelrod FB, Rolnitzky L, Gold von Simson G, Berlin D, Kaufmann H.

J Pediatr. 2012 Dec;161(6):1160-5. doi: 10.1016/j.jpeds.2012.05.038. Epub 2012 Jun 23.

17.

Combined counter-maneuvers accelerate recovery from orthostatic hypotension in familial dysautonomia.

Hilz MJ, Ehmann EC, Pauli E, Baltadzhieva R, Koehn J, Moeller S, DeFina P, Axelrod FB.

Acta Neurol Scand. 2012 Sep;126(3):162-70. doi: 10.1111/j.1600-0404.2012.01670.x. Epub 2012 May 10.

PMID:
22571291
18.

Hereditary sensory autonomic neuropathy caused by a mutation in dystonin.

Edvardson S, Cinnamon Y, Jalas C, Shaag A, Maayan C, Axelrod FB, Elpeleg O.

Ann Neurol. 2012 Apr;71(4):569-72. doi: 10.1002/ana.23524.

PMID:
22522446
19.

Genome-wide analysis of familial dysautonomia and kinetin target genes with patient olfactory ecto-mesenchymal stem cells.

Boone N, Bergon A, Loriod B, Devèze A, Nguyen C, Axelrod FB, Ibrahim EC.

Hum Mutat. 2012 Mar;33(3):530-40. doi: 10.1002/humu.22010. Epub 2012 Jan 17.

PMID:
22190446
20.

Developmental abnormalities, blood pressure variability and renal disease in Riley Day syndrome.

Norcliffe-Kaufmann L, Axelrod FB, Kaufmann H.

J Hum Hypertens. 2013 Jan;27(1):51-5. doi: 10.1038/jhh.2011.107. Epub 2011 Dec 1.

21.

Can loss of muscle spindle afferents explain the ataxic gait in Riley-Day syndrome?

Macefield VG, Norcliffe-Kaufmann L, Gutiérrez J, Axelrod FB, Kaufmann H.

Brain. 2011 Nov;134(Pt 11):3198-208. doi: 10.1093/brain/awr168.

22.

Clinical neuro-ophthalmic findings in familial dysautonomia.

Mendoza-Santiesteban CE, Hedges TR 3rd, Norcliffe-Kaufmann L, Warren F, Reddy S, Axelrod FB, Kaufmann H.

J Neuroophthalmol. 2012 Mar;32(1):23-6. doi: 10.1097/WNO.0b013e318230feab.

23.

Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia.

Axelrod FB, Liebes L, Gold-Von Simson G, Mendoza S, Mull J, Leyne M, Norcliffe-Kaufmann L, Kaufmann H, Slaugenhaupt SA.

Pediatr Res. 2011 Nov;70(5):480-3. doi: 10.1203/PDR.0b013e31822e1825.

24.

Cardiovascular and neuroendocrine features of Panayiotopoulos syndrome in three siblings.

Gonzalez-Duarte A, Norcliffe-Kaufmann L, Martinez J, Rodriguez AJ, Kuzniecky R, Axelrod F, Kaufmann H.

Epilepsy Behav. 2011 Jul;21(3):296-300. doi: 10.1016/j.yebeh.2011.03.006. Epub 2011 Apr 7.

PMID:
21474385
25.

Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.

Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, van Dijk JG.

Clin Auton Res. 2011 Apr;21(2):69-72. doi: 10.1007/s10286-011-0119-5. No abstract available.

PMID:
21431947
26.

Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.

Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz IJ, Schondorf R, Stewart JM, van Dijk JG.

Auton Neurosci. 2011 Apr 26;161(1-2):46-8. doi: 10.1016/j.autneu.2011.02.004. Epub 2011 Mar 9. No abstract available.

PMID:
21393070
27.

Increased Incidence of Tumors With the IKBKAP Gene Mutation? A Case Report and Review of the Literature.

Shvartsbeyn M, Rapkiewicz A, Axelrod F, Kaufmann H.

World J Oncol. 2011 Feb;2(1):41-44. doi: 10.4021/wjon278w. Epub 2011 Feb 26.

28.

Assessing autonomic dysfunction symptoms in children: a pilot study.

Ming X, Bain JM, Smith D, Brimacombe M, Gold von-Simson G, Axelrod FB.

J Child Neurol. 2011 Apr;26(4):420-7. doi: 10.1177/0883073810381921. Epub 2010 Dec 31.

PMID:
21196528
29.

Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia.

Boone N, Loriod B, Bergon A, Sbai O, Formisano-Tréziny C, Gabert J, Khrestchatisky M, Nguyen C, Féron F, Axelrod FB, Ibrahim EC.

PLoS One. 2010 Dec 20;5(12):e15590. doi: 10.1371/journal.pone.0015590.

30.

Afferent baroreflex failure in familial dysautonomia.

Norcliffe-Kaufmann L, Axelrod F, Kaufmann H.

Neurology. 2010 Nov 23;75(21):1904-11. doi: 10.1212/WNL.0b013e3181feb283.

31.

Complicated peptic ulcer disease in three patients with familial dysautonomia.

Wan DW, Levy J, Ginsburg HB, Kaufmann H, Axelrod FB.

J Clin Gastroenterol. 2011 Aug;45(7):611-3. doi: 10.1097/MCG.0b013e3181e5e8ed.

PMID:
20930641
32.

Renal transplantation in familial dysautonomia: report of two cases and review of the literature.

Rekhtman Y, Bomback AS, Nash MA, Cohen SD, Matalon A, Jan DM, Kaufmann H, Axelrod FB, Radhakrishnan J, Appel GB.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1676-80. doi: 10.2215/CJN.01750210. Epub 2010 Jun 17. Review.

33.

Neoplasia in familial dysautonomia: a 20-year review in a young patient population.

Gold-von Simson G, Romanos-Sirakis E, Maayan C, Axelrod FB.

J Pediatr. 2009 Dec;155(6):934-6. doi: 10.1016/j.jpeds.2009.04.055.

PMID:
19914433
34.

Neuroimaging supports central pathology in familial dysautonomia.

Axelrod FB, Hilz MJ, Berlin D, Yau PL, Javier D, Sweat V, Bruehl H, Convit A.

J Neurol. 2010 Feb;257(2):198-206. doi: 10.1007/s00415-009-5293-1. Epub 2009 Aug 25.

PMID:
19705052
35.

DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency.

Hoey T, Yen WC, Axelrod F, Basi J, Donigian L, Dylla S, Fitch-Bruhns M, Lazetic S, Park IK, Sato A, Satyal S, Wang X, Clarke MF, Lewicki J, Gurney A.

Cell Stem Cell. 2009 Aug 7;5(2):168-77. doi: 10.1016/j.stem.2009.05.019.

36.

Pregabalin: a new approach to treatment of the dysautonomic crisis.

Axelrod FB, Berlin D.

Pediatrics. 2009 Aug;124(2):743-6. doi: 10.1542/peds.2008-3318. Epub 2009 Jul 20.

PMID:
19620195
37.

Peripheral arthropathy in hereditary sensory and autonomic neuropathy types III and IV.

Feldman DS, Ruchelsman DE, Spencer DB, Straight JJ, Schweitzer ME, Axelrod FB.

J Pediatr Orthop. 2009 Jan-Feb;29(1):91-7. doi: 10.1097/BPO.0b013e31818f9cc4.

PMID:
19098654
38.

The R3 component of the electrically elicited blink reflex is present in patients with congenital insensitivity to pain.

Téllez MJ, Axelrod F, Kaufmann H.

Pain. 2009 Jan;141(1-2):178-80. doi: 10.1016/j.pain.2008.10.030. Epub 2008 Dec 11.

PMID:
19084335
39.

Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing.

Gold-von Simson G, Goldberg JD, Rolnitzky LM, Mull J, Leyne M, Voustianiouk A, Slaugenhaupt SA, Axelrod FB.

Pediatr Res. 2009 Mar;65(3):341-6. doi: 10.1203/PDR.0b013e318194fd52.

PMID:
19033881
40.

Advanced electrocardiographic predictors of mortality in familial dysautonomia.

Solaimanzadeh I, Schlegel TT, Feiveson AH, Greco EC, DePalma JL, Starc V, Marthol H, Tutaj M, Buechner S, Axelrod FB, Hilz MJ.

Auton Neurosci. 2008 Dec 15;144(1-2):76-82. doi: 10.1016/j.autneu.2008.08.016. Epub 2008 Oct 11.

PMID:
18851930
41.

Cardiac sympathetic hypo-innervation in familial dysautonomia.

Goldstein DS, Eldadah B, Sharabi Y, Axelrod FB.

Clin Auton Res. 2008 Jun;18(3):115-9. doi: 10.1007/s10286-008-0464-1. Epub 2008 May 22.

42.

Plasma catechols in familial dysautonomia: a long-term follow-up study.

Goldstein DS, Holmes C, Axelrod FB.

Neurochem Res. 2008 Sep;33(9):1889-93. doi: 10.1007/s11064-008-9662-4. Epub 2008 Mar 21.

43.

IKBKAP mRNA in peripheral blood leukocytes: a molecular marker of gene expression and splicing in familial dysautonomia.

Gold-von Simson G, Leyne M, Mull J, Rolnitzky LM, Goldberg JD, Berlin D, Axelrod FB, Slaugenhaupt SA.

Pediatr Res. 2008 Feb;63(2):186-90.

PMID:
18091349
44.

Hereditary sensory and autonomic neuropathies: types II, III, and IV.

Axelrod FB, Gold-von Simson G.

Orphanet J Rare Dis. 2007 Oct 3;2:39. Review.

45.

A reinforced suture line prevents recurrence after fundoplication in patients with familial dysautonomia.

Nadler EP, Leung S, Axelrod FB, Ginsburg HB.

J Pediatr Surg. 2007 Apr;42(4):653-6.

PMID:
17448761
46.

Prevalence and severity of renal disease in familial dysautonomia.

Elkayam L, Matalon A, Tseng CH, Axelrod F.

Am J Kidney Dis. 2006 Nov;48(5):780-6.

PMID:
17059997
47.

Pediatric autonomic disorders.

Axelrod FB, Chelimsky GG, Weese-Mayer DE.

Pediatrics. 2006 Jul;118(1):309-21. Review.

PMID:
16818580
48.

Familial dysautonomia: update and recent advances.

Gold-von Simson G, Axelrod FB.

Curr Probl Pediatr Adolesc Health Care. 2006 Jul;36(6):218-37. Review. No abstract available.

PMID:
16777588
49.

Familial dysautonomia's impact on quality of life in childhood, adolescence, and adulthood.

Sands SA, Giarraffa P, Jacobson CM, Axelrod FB.

Acta Paediatr. 2006 Apr;95(4):457-62.

PMID:
16720494
50.

Anesthesia management of familial dysautonomia.

Ngai J, Kreynin I, Kim JT, Axelrod FB.

Paediatr Anaesth. 2006 Jun;16(6):611-20. Review.

PMID:
16719876

Supplemental Content

Loading ...
Support Center